https://www.selleckchem.com/pr....oducts/molidustat-(b
62 [95% CI 3.33-3.92] compared with age less then 45y; moderately-impaired, HR 1.68 [95% CI 1.45-1.95]; severely-impaired, HR 4.80 [95% CI 3.71-6.21] compared with non-impaired). Lower KPS was associated with higher risk of death/delisting among all ages, but this effect was slightly less pronounced among individuals aged ≥65 years. Performance status should be used when counselling patients with ESRD on their risks for death/delisting. This article is protected by copyright. All rights reserved.We determined the relativ
Like
Comment
Share
